 Stamulumab

Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD).Stamulumab was formulated and tested by Wyeth in Collegeville, Pennsylvania.